Cite
HARVARD Citation
Gajzer, D. et al. (2022). Probability of malignancy as determined by ThyroSeq v3 genomic classifier varies according to the subtype of atypia. Cancer cytopathology. 130 (11), pp. 881-890. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gajzer, D. et al. (2022). Probability of malignancy as determined by ThyroSeq v3 genomic classifier varies according to the subtype of atypia. Cancer cytopathology. 130 (11), pp. 881-890. [Online].